MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine

March 27, 2023

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.

■Mitsubishi Tanabe Pharma　Press Release
Approval of “GOBIK Aqueous Suspension Syringes”, Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine
https://www.mt-pharma.co.jp/e/news/assets/pdf/e_MTPC230327_2.pdf



・Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top